AUA 2021

REVIEW UroToday

Viewing 1-20 of 81 articles

AUA 2021: Pre-Surgical Multiparametric Magnetic Resonance Imaging Features Predicting Continence After Robotic Radical Cystectomy With Orthotopic Bladder Reconstruction: Preliminary Findings Form PURE-01 Trial

AUA 2021: Utility of Blue Light Flexible Cystoscopy for Bladder Cancer Surveillance after Intravesical Therapy

AUA 2021: Intravesical Therapy in Patients with Intermediate-Risk Non-Muscle-Invasive Bladder Cancer: A Systematic Review and Network Meta-Analysis of Oncologic Outcomes

AUA 2021: Impact of the COVID Pandemic on the Diagnosis and Treatment of Urologic Cancers

AUA 2021: Avelumab First-Line Maintenance for Advanced Urothelial Carcinoma in the JAVELIN Bladder 100 Trial: Subgroup Analysis by Duration of Treatment-Free Interval from End of Chemotherapy to Start of Maintenance

ImmunityBio Announces Positive Durable Responses in BCG Unresponsive Bladder Cancer Patients with a Complete Response Rate of 72%, Median Duration of Complete Response of 19.9 Months, and 85% Remaining Cystectomy-free in Phase 2/3 Trial

AUA 2021: Prospective Study of 68Ga-RM2 PET/MRI in Patients With Biochemically Recurrent Prostate Cancer and Negative Conventional Imaging

AUA 2021: A High Through-Put Test Interrogating 442 Small Non-Coding RNAs Extracted from Urine Exosomes Accurately Identifies and Stratifies Prostate Cancer into Low-, Intermediate- or High-Risk Disease

AUA 2021: Masitinib Plus Docetaxel as First-Line Treatment of Metastatic Castrate Refractory Prostate Cancer: Results from Study AB12003

AUA 2021: MRI-guided Focused Ultrasound Focal Therapy for Intermediate-Risk Prostate Cancer: Final Results of a Phase IIb Multicenter Study

AUA 2021: The IMPROVE Trial: Surgical Technique Remains the Most Important Factor Associated with Recovery of Urinary Continence After Radical Prostatectomy

AUA 2021: NAXIVA - A Phase II Neoadjuvant Study of Axitinib for Reducing Extent of Venous Tumor Thrombus in Clear Cell Renal Cell Cancer with Venous Invasion: Translational Results

AUA 2021: Long-Term Recurrence Free Survival Following UGN-101 Treatment for Low-Grade Upper Tract Urothelial Carcinoma

AUA 2021: Prospective Evaluation of 18F-DCFPyL PET/CT in Biochemically Recurrent Prostate Cancer: Analysis of 18F-DCFPyL Uptake in Possible Extra-Pelvic Oligometastases

Urovant Sciences Presents Positive Ambulatory Blood Pressure Data Showing That GEMTESA® (vibegron) 75 mg in Overactive Bladder Was Not Associated with Statistically Significant or Clinically Meaningful Effects on Blood Pressure or Heart Rate

AUA 2021: Female Patients With Low-Grade Upper Tract Urothelial Carcinoma: Primary Chemoablation and Durability of Response in a Subgroup Analysis From the OLYMPUS Trial

AUA 2021: Perioperative Intravesical Chemotherapy in Minimally Invasive Radical Nephroureterectomy for Upper Tract Urothelial Carcinoma: Low but Increasing Utilization Worldwide

AUA 2021: A Phase II Randomized Clinical Trial Of Yoga In Men With Prostate Cancer

AUA 2021: Novel Weekly Immunotherapy Dosing with Avelumab Tolerated During Bacillus Calmette-Guerin Induction Therapy: Initial Results of the ABC Trial

AUA 2021: Persistent Deficiencies in the Measurement and Reporting of Tobacco Use in Contemporary Genitourinary Oncology Clinical Trials

1
2
3
4
5